CompletedNot Applicable

Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy Using the Rotundum Device in Retirement Homes

Switzerland453 participantsStarted 2018-11-25

Plain-language summary

Benign paroxysmal positional vertigo (BPPV) is one of the most common types of vertigo, especially in elderly. Therefore the investigators have set the goal to evaluate the prevalence of BPPV and its therapy using the Rotundum device in elderly living in retirement homes. Furthermore the investigators use a questionnaire to evaluate possible predictive signs to improve the diagnosis of this disease.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Lives in retirement home/has vertigo/has signed the informed consent Exclusion Criteria: * severe heart failure * untreated cardiac arrythmia * severe autonomic Dysregulation * untreated epilepsy * untreated cervical vertebral body fracture * inability to follow the test * weight over 150kg or under 40kg * height below 140cm or over 200cm * bedridden * already participated this study * participant is connected to the study team

What they're measuring

Prevalence of BPPV

Timeframe: Subjects (outcome measure) are assessed during the first 4 Years

Trial details

NCT IDNCT03643354

SponsorUniversity of Zurich

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-01

View on ClinicalTrials.gov More Benign Paroxysmal Positional Vertigo trials